CBP-501 acetate
Product Specifications
Target
MAPK, MAP3K, CaMK, Chk, Calmodulin
Related Pathways
Cell Cycle/Checkpoint, Neuroscience, MAPK, Membrane transporter/Ion channel
Bioactivity
CBP-501 acetate is a cell-permeable calmodulin-binding peptide and a candidate G2 phase checkpoint abrogator. It inhibits several Ser216-specific kinases, including MAPKAP-K2, C-Tak1, CHK1, and CHK2, with IC50 values of 0.9 μM, 1.4 μM, 3.4 μM, and 6.5 μM, respectively. CBP-501 acetate is applicable to various cancer research studies.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog